Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-3

Eli Lilly · Phase 3 · Completed · Enrollment 579

NCT04657016

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

X axis: threshold category. Y axis: participants reaching threshold, %.

94.3710.65
≥5%
88.034.81
≥10%
73.942.06
≥15%
54.931.03
≥20%
Show as table
Arm≥5%≥10%≥15%≥20%
Tirzepatide94.37%88.03%73.94%54.93%
Placebo10.65%4.81%2.06%1.03%

Not shown

Every selected arm is drawn.